WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
VKTX
VIKING THERAPEUTICS INC
$8.35B$0.00-$93.43M-$93.72M-$0.93N/AN/AN/AN/A2024-05-21
ANTX
AN2 THERAPEUTICS INC
$75.62M$0.00-$64.68M-$64.73M-$2.74N/AN/AN/AN/A2024-05-08
ADIL
ADIAL PHARMACEUTICALS INC
$7.26M$0.00-$5.12M-$5.12M-$3.60N/AN/AN/AN/A2024-05-10
INSM
INSMED INC
$3.81B$305.21M-$645.53M-$749.57M-$5.3424.39%98.78%N/AN/A2024-05-09
NKTR
NEKTAR THERAPEUTICS
$306.64M$90.12M-$243.11M-$276.06M-$1.45-2.10%-40.35%N/AN/A2024-06-05
IKT
INHIBIKASE THERAPEUTICS INC
$8.68M$260.50k-$18.85M-$19.03M-$3.57111.03%-42.21%N/AN/A2024-06-07
NUVL
NUVALENT INC
$4.64B$0.00-$126.22M-$126.22M-$2.17N/AN/AN/AN/A2024-05-09
TCBP
TC BIOPHARM (HOLDINGS) PLC
$4.63M$0.00-$8.05M-$7.57M-$24.62-100.00%N/AN/AN/A
ABVX
ABIVAX SA
$938.90M$5.02M-$129.52M-$160.59M-$3.735.31%N/AN/AN/A2024-05-30
TCON
TRACON PHARMACEUTICALS INC
$4.12M$12.05M$3.75M-$3.59M-$2.20N/A32.05%N/AN/A2024-05-08
GRTS
GRITSTONE BIO INC
$85.32M$16.34M-$112.80M-$138.49M-$1.20-18.05%68.96%N/AN/A2024-06-17
VALN
VALNEVA SE
$515.78M$167.08M-$81.85M-$110.25M-$1.59-55.57%N/AN/AN/A2024-06-26
AVTE
AEROVATE THERAPEUTICS INC
$578.16M$0.00-$75.37M-$75.52M-$2.87N/AN/AN/AN/A2024-05-13
TENX
TENAX THERAPEUTICS INC
$7.42M$0.00-$7.68M-$7.71M-$31.04N/AN/AN/AN/A2024-05-13
ABUS
ARBUTUS BIOPHARMA CORP
$505.76M$12.99M-$72.66M-$74.39M-$0.44-60.80%20.14%N/AN/A
LIPO
LIPELLA PHARMACEUTICALS INC
$4.69M$449.62k-$4.61M-$4.62M-$0.77144.15%N/AN/AN/A
OBIO
ORCHESTRA BIOMED HOLDINGS INC
$198.56M$2.76M-$48.20M-$49.12M-$1.48-21.88%N/AN/AN/A
ACLX
ARCELLX INC
$2.81B$110.32M-$44.26M-$70.69M-$1.47N/AN/AN/AN/A2024-05-08
ACRV
ACRIVON THERAPEUTICS INC
$191.51M$0.00-$59.07M-$60.39M-$2.74N/AN/AN/AN/A2024-05-07
CTXR
CITIUS PHARMACEUTICALS INC
$112.48M$0.00-$37.41M-$39.33M-$0.26N/AN/AN/AN/A2024-05-10
PYXS
PYXIS ONCOLOGY INC
$256.37M$0.00-$71.20M-$73.79M-$1.85N/AN/AN/AN/A2024-06-11
CYTO
ALTAMIRA THERAPEUTICS LTD
$2.39M$0.00-$2.31M-$4.30M-$8.76N/AN/AN/AN/A2024-05-16
DAWN
DAY ONE BIOPHARMACEUTICALS INC
$1.54B$0.00-$188.53M-$188.92M-$2.37N/AN/AN/AN/A2024-05-09
RLAY
RELAY THERAPEUTICS INC
$939.81M$35.33M-$323.65M-$329.12M-$2.642,873.65%N/AN/AN/A2024-06-03
JSPR
JASPER THERAPEUTICS INC
$361.23M$0.00-$62.94M-$64.47M-$6.18N/AN/AN/AN/A2024-06-06
VBIV
VBI VACCINES INC
$16.58M$8.68M-$84.45M-$93.84M-$6.03702.40%20.94%N/AN/A2024-06-25
ENTA
ENANTA PHARMACEUTICALS INC
$294.28M$73.62M-$124.91M-$138.24M-$6.56-10.32%-20.94%N/AN/A2024-05-06
GLUE
MONTE ROSA THERAPEUTICS INC
$280.86M$0.00-$128.79M-$135.35M-$2.63N/AN/AN/AN/A2024-05-09
IONS
IONIS PHARMACEUTICALS INC
$6.28B$787.65M-$230.01M-$366.29M-$2.5634.10%5.60%N/AN/A2024-05-14
NTRB
NUTRIBAND INC
$40.04M$2.09M-$5.09M-$5.49M-$0.690.27%53.43%N/AN/A
TNXP
TONIX PHARMACEUTICALS HOLDING CORP
$14.45M$7.77M-$112.37M-$116.66M-$6.85N/AN/AN/AN/A2024-05-22
LGVN
LONGEVERON INC
$4.55M$709.00k-$20.47M-$22.21M-$10.20-41.98%-19.78%N/AN/A2024-05-10
MRSN
MERSANA THERAPEUTICS INC
$407.58M$36.86M-$163.30M-$171.67M-$1.4838.65%28.32%N/AN/A2024-06-11
ASND
ASCENDIS PHARMA A
$8.22B$353.79M-$381.48M-$539.32M-$9.54322.18%81.53%N/AN/A
FNCH
FINCH THERAPEUTICS GROUP INC
$4.00M$107.00k-$75.60M-$74.75M-$46.59-87.57%N/AN/AN/A
BTAI
BIOXCEL THERAPEUTICS INC
$78.28M$1.38M-$165.42M-$179.05M-$6.15268.00%N/AN/AN/A2024-05-09
CDMO
AVID BIOSERVICES INC
$520.53M$136.74M-$7.83M-$17.98M-$0.28-2.81%25.75%N/AN/A2024-06-19
MOR
MORPHOSYS AG
$2.69B$259.00M-$41.75M-$206.23M-$1.50-10.56%24.68%N/AN/A2024-05-16
IOVA
IOVANCE BIOTHERAPEUTICS INC
$3.60B$1.19M-$414.39M-$444.04M-$1.89N/AN/AN/AN/A2024-05-09
SEEL
SEELOS THERAPEUTICS INC
$4.51M$2.20M-$37.75M-$37.88M-$7.73N/AN/AN/AN/A2024-05-13
GANX
GAIN THERAPEUTICS INC
$47.52M$55.18k-$22.10M-$22.27M-$1.71-60.62%21.77%N/AN/A2024-06-24
EYEN
EYENOVIA INC
$44.40M$3.79k-$24.11M-$27.26M-$0.66N/AN/AN/AN/A2024-06-12
FENC
FENNEC PHARMACEUTICALS INC
$246.34M$21.25M-$12.65M-$16.05M-$0.601,284.50%N/AN/AN/A2024-05-09
XNCR
XENCOR INC
$1.44B$168.34M-$108.78M-$126.09M-$2.082.28%32.90%N/AN/A2024-06-13
PYPD
POLYPID LTD
$7.94M$0.00-$21.05M-$23.87M$16.99N/AN/A-72.19%28.76%2024-05-08
SGMO
SANGAMO THERAPEUTICS INC
$93.39M$176.23M-$240.71M-$257.83M-$1.4858.34%15.85%N/AN/A2024-06-04
THAR
THARIMMUNE INC
$4.44M$0.00-$9.30M-$9.32M-$7.14N/AN/AN/AN/A
APGE
APOGEE THERAPEUTICS INC
$2.64B$0.00-$83.90M-$83.99M-$3.36N/AN/AN/AN/A
APM
APTORUM GROUP LTD
$28.03M$431.38k-$1.33M-$2.82M-$0.62-66.71%2.38%N/AN/A
AZTR
AZITRA INC
$6.34M$686.00k-$10.67M-$12.64M-$1.83141.55%N/AN/AN/A
ALLK
ALLAKOS INC
$96.66M$0.00-$188.42M-$185.70M-$2.14N/AN/AN/AN/A2024-05-24
BCAB
BIOATLA INC
$151.99M$0.00-$122.24M-$123.46M-$2.58N/A-100.00%N/AN/A2024-06-13
APLT
APPLIED THERAPEUTICS INC
$479.67M$9.99M-$119.41M-$119.76M-$1.42N/AN/AN/AN/A2024-05-09
CAPR
CAPRICOR THERAPEUTICS INC
$164.53M$25.18M-$21.22M-$22.29M-$0.83886.81%72.02%N/AN/A2024-05-14
GTBP
GT BIOPHARMA INC
$4.41M$0.00-$7.38M-$7.60M-$5.64N/AN/AN/AN/A2024-06-25
CMND
CLEARMIND MEDICINE INC
$3.71M$0.00-$7.85M-$8.09M-$31.18N/AN/AN/AN/A
CRIS
CURIS INC
$97.31M$10.02M-$45.81M-$47.41M-$8.96-1.37%-0.79%N/AN/A2024-05-07
MBRX
MOLECULIN BIOTECH INC
$11.47M$0.00-$29.64M-$29.77M-$15.07N/AN/AN/AN/A2024-06-14
CTNM
CONTINEUM THERAPEUTICS INC
N/A$50.00M$4.96M$3.15M$1.36N/AN/AN/AN/A
EDSA
EDESA BIOTECH INC
$14.45M$0.00-$7.52M-$7.72M-$2.63N/AN/AN/AN/A2024-05-30
ELEV
ELEVATION ONCOLOGY INC
$208.72M$0.00-$39.39M-$39.35M-$0.98N/AN/AN/AN/A
ENLV
ENLIVEX THERAPEUTICS LTD
$30.13M$0.00-$28.56M-$29.07M-$1.56N/AN/AN/AN/A2024-06-24
ENVB
ENVERIC BIOSCIENCES INC
$6.75M$0.00-$16.86M-$17.46M-$8.09N/A-100.00%N/AN/A2024-05-28
GHRS
GH RESEARCH PLC
$582.19M$0.00-$34.55M-$35.59M-$0.68N/AN/AN/AN/A2024-05-15
HLVX
HILLEVAX INC
$696.81M$0.00-$119.02M-$123.57M-$3.04N/AN/AN/AN/A2024-06-05
OPT
OPTHEA LTD
$193.87M$385.28k-$134.99M-$142.52M-$2.5893.60%N/AN/AN/A
RARE
ULTRAGENYX PHARMACEUTICAL INC
$3.56B$434.25M-$582.46M-$606.64M-$8.2519.52%53.18%N/AN/A2024-06-18
RVNC
REVANCE THERAPEUTICS INC
$332.57M$234.04M-$290.64M-$323.99M-$3.8376.55%128.84%N/AN/A2024-05-06
SYRE
SPYRE THERAPEUTICS INC
$1.31B$886.00k-$337.85M-$338.79M-$49.12-61.96%-25.61%N/AN/A2024-05-13
MGTX
MEIRAGTX HOLDINGS PLC
$320.44M$0.00-$57.05M-$84.03M-$1.49N/AN/AN/AN/A2024-05-09
RPHM
RENEO PHARMACEUTICALS INC
$57.82M$0.00-$76.86M-$77.39M-$2.52N/AN/AN/AN/A2024-06-05
MLYS
MINERALYS THERAPEUTICS INC
$649.67M$0.00-$71.90M-$71.90M-$1.99N/AN/AN/AN/A2024-05-13
TLSA
TIZIANA LIFE SCIENCES LTD
$72.10M$0.00-$15.34M-$15.40M-$0.15N/AN/AN/AN/A
TNYA
TENAYA THERAPEUTICS INC
$362.74M$0.00-$112.27M-$124.08M-$1.68N/AN/AN/AN/A2024-05-08
SLDB
SOLID BIOSCIENCES INC
$386.25M$0.00-$93.43M-$96.02M-$4.83-100.00%N/AN/AN/A2024-06-11
TSHA
TAYSHA GENE THERAPIES INC
$482.51M$15.45M-$104.02M-$111.57M-$0.96517.55%N/AN/AN/A2024-05-29
PEPG
PEPGEN INC
$468.82M$0.00-$77.37M-$78.63M-$3.30N/AN/AN/AN/A2024-06-13
ONCY
ONCOLYTICS BIOTECH INC
$87.08M$0.00-$20.04M-$20.41M-$0.30N/AN/AN/AN/A2024-05-15
VIRI
VIRIOS THERAPEUTICS INC
$8.11M$0.00-$5.30M-$5.30M-$0.28N/AN/AN/AN/A2024-05-09
VIRX
VIRACTA THERAPEUTICS INC
$32.99M$0.00-$46.86M-$51.06M-$1.32N/A-100.00%N/AN/A2024-06-18
VTYX
VENTYX BIOSCIENCES INC
$290.93M$0.00-$192.02M-$192.96M-$3.30N/AN/AN/AN/A2024-06-05
XFOR
X4 PHARMACEUTICALS INC
$181.37M$0.00-$93.32M-$101.17M-$0.57N/AN/AN/AN/A2024-05-07
PHVS
PHARVARIS NV
$1.23B$0.00-$103.93M-$108.47M-$2.83N/AN/AN/AN/A2024-06-21
DYN
DYNE THERAPEUTICS INC
$2.27B$0.00-$255.00M-$257.40M-$3.97N/AN/AN/AN/A2024-05-22
GNTA
GENENTA SCIENCE SPA
$60.30M$0.00-$12.28M-$12.66M-$0.70N/AN/AN/AN/A
BLTE
BELITE BIO INC
$1.20B$0.00-$31.20M-$31.63M-$1.19N/AN/AN/AN/A2024-05-08
IMMX
IMMIX BIOPHARMA INC
$60.98M$0.00-$15.39M-$15.43M-$0.89N/AN/AN/AN/A
GLSI
GREENWICH LIFESCIENCES INC
$180.17M$0.00-$8.89M-$8.89M-$0.69N/AN/AN/AN/A2024-05-22
BMEA
BIOMEA FUSION INC
$428.82M$0.00-$122.55M-$127.27M-$3.57N/AN/AN/AN/A2024-05-13
PDSB
PDS BIOTECHNOLOGY CORP
$136.81M$0.00-$42.87M-$42.94M-$1.39N/AN/AN/AN/A2024-06-24
CMMB
CHEMOMAB THERAPEUTICS LTD
$10.44M$0.00-$24.15M-$24.22M-$2.06N/AN/AN/AN/A2024-05-09
CYCC
CYCLACEL PHARMACEUTICALS INC
$3.28M$420.00k-$25.52M-$22.76M-$26.75N/A22.87%N/AN/A2024-06-12
CDXS
CODEXIS INC
$235.66M$74.23M-$55.83M-$65.13M-$0.93-36.13%3.62%N/AN/A
GNPX
GENPREX INC
$4.51M$0.00-$30.85M-$30.86M-$22.56N/AN/AN/AN/A2024-05-22
KPTI
KARYOPHARM THERAPEUTICS INC
$124.27M$146.03M-$118.42M-$143.10M-$1.25-7.03%36.93%N/AN/A2024-05-29
RLYB
RALLYBIO CORP
$69.20M$0.00-$74.41M-$74.56M-$1.84N/AN/AN/AN/A2024-05-07
SLN
SILENCE THERAPEUTICS PLC
$842.97M$32.12M-$60.37M-$54.77MN/A52.33%N/AN/AN/A2024-05-14
SLRX
SALARIUS PHARMACEUTICALS INC
$2.28M$0.00-$12.53M-$12.54M-$3.84N/A-100.00%N/AN/A2024-06-13
CGTX
COGNITION THERAPEUTICS INC
$77.22M$0.00-$25.51M-$25.79M-$0.86N/AN/AN/AN/A2024-05-04
CKPT
CHECKPOINT THERAPEUTICS INC
$52.82M$103.00k-$51.85M-$51.85M-$3.17-46.35%-50.61%N/AN/A2024-05-13

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 11.92% over the past year, overperforming other biotech stocks by 30 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 62.28% from Corcept Therapeutics's current stock price of $25.06.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -24.11% over the past year, underperforming other biotech stocks by -6 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 41.12% from Incyte's current stock price of $53.09.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -92.81% over the past year, underperforming other biotech stocks by -74 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 450% from Amylyx Pharmaceuticals's current stock price of $2.00.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.11%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.42%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.42% in the last day, and up 6.14% over the last week. Context Therapeutics was the among the top gainers in the biotechnology industry, gaining 28.68% yesterday.

Context Therapeutics shares are trading higher after the company announced FDA clearance of its IND application for a Phase 1 clinical trial of CTIM-76.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -24.11% in the past year. It has underperformed other stocks in the biotech industry by -6 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -17.97% in the past year. It has performed in line with other stocks in the biotech industry.

3. Avrobio (NASDAQ:AVRO)


Avrobio (NASDAQ:AVRO) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Avrobio has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Avrobio's stock has gained 88.65% in the past year. It has overperformed other stocks in the biotech industry by 107 percentage points.

Are biotech stocks a good buy now?

49.33% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 82.13% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 7.63x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.